Skip to main content
Fig. 4 | Trials

Fig. 4

From: Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)

Fig. 4

Once the targeted muscular injection points are selected (upper panel), repeated administrations of cell therapy are directly, easily, and minimally invasive administered into the lower part of the limb (lower panel)

Back to article page

Trials

ISSN: 1745-6215